QC Kinetix, a leader in regenerative medicine, marks a new milestone with the appointment of Dr. Mitchell Sheinkop as its National Medical Director. A globally recognized orthopedic surgeon and pioneer in the field, Dr. Sheinkop brings extensive expertise to the role, promising to drive innovation and enhance patient care.
Dr. Mitchell Sheinkop: A Leader in Regenerative Medicine
With over 40 years of experience as a surgeon, educator, and regenerative medicine specialist, Dr. Sheinkop is excited to join QC Kinetix, drawn by its groundbreaking approach and commitment to advancing non-surgical treatment options.
The company continues its rapid expansion, ranking No. 1 on the Franchise Times’ Fast & Serious List and securing the No. 9 spot on Entrepreneur magazine’s 2024 list of Top New and Emerging Franchises.
“Joining QC Kinetix presents an incredible opportunity to push the boundaries of regenerative medicine,” Dr. Sheinkop stated. “I look forward to collaborating with the team to refine treatment protocols and enhance patient care across our clinics.”
About QC Kinetix
Headquartered in Charlotte, North Carolina, QC Kinetix is a franchise-based regenerative medicine provider specializing in non-surgical treatments for musculoskeletal and joint pain. The company utilizes cutting-edge biologic therapies designed to promote the body’s natural healing process as an alternative to surgery and pain medications.
Since opening its first clinic in Charleston, South Carolina, in 2017, QC Kinetix has grown to hundreds of locations across 100+ cities. Its concierge-style clinics now offer an expanded range of services, including hair restoration and men’s hormone replacement therapy.
Dr. Sheinkop’s Role at QC Kinetix
As National Medical Director, Dr. Sheinkop will lead the company’s medical team with a focus on:
- Enhancing treatment protocols to improve patient results
- Advancing research and development in regenerative medicine
- Incorporating physical therapy and weight loss into treatment programs
- Refining practitioner training and certification to uphold clinical excellence
QC Kinetix’s CEO expressed enthusiasm for Dr. Sheinkop’s appointment, stating:
“We are thrilled to have Dr. Sheinkop on board. His expertise, innovative thinking, and dedication to regenerative medicine make him the perfect fit for our team. His leadership will help QC Kinetix reach new levels of success and deliver exceptional care to patients nationwide.”
QC Kinetix’s Growth and Future Expansion
Looking ahead, QC Kinetix aims to open 250 locations in the U.S. by the end of 2024, with plans for international expansion into the United Kingdom and Australia.
“As we expand, we remain committed to being a leader in regenerative medicine. Our goal is to change more lives with advanced, non-surgical treatments,” said the CEO.
Dr. Sheinkop’s Medical Background and Achievements
A Chicago native, Dr. Sheinkop earned his undergraduate degree from the University of Illinois, attended Chicago Medical School, and completed his residency at Northwestern University. His career has taken him across the globe, with professional engagements in the UAE, Saudi Arabia, Istanbul, Hungary, Switzerland, Poland, Russia, Romania, and Austria.
As an authority in orthopedics and regenerative medicine, he has published over 70 research papers in leading medical journals.
Reflecting on his career, he shared:
“My success in medicine is built on hard work, seizing opportunities, and a bit of luck. I chose orthopedics during the Vietnam War era due to high demand for specialists in this field.”
Dr. Sheinkop also served in the United States Air Force Reserve as a first lieutenant and captain in the Medical Corps. Today, he lives in Chicago with his wife of 56 years, Sharon, and enjoys gardening and skiing, reinforcing the role of regenerative medicine in maintaining an active lifestyle.
The Advancements of Regenerative Medicine
Regenerative medicine has evolved significantly over the last decade. According to the Mayo Clinic’s Center for Regenerative Medicine, founded in 2011:
“Regenerative medicine seeks to go beyond managing disease, focusing on therapies that enable the body to repair, regenerate, and restore itself to a state of well-being.”
Dr. Sheinkop has played a key role in advancing biologic treatments that harness the body’s natural healing capabilities. His work continues to shape the future of regenerative care, improving patient outcomes through innovative therapies.
The Future of QC Kinetix
Since launching its franchise model in 2020, QC Kinetix has achieved exponential growth, with millions in sales and a growing presence across the U.S. The “QC” in QC Kinetix pays homage to Charlotte, North Carolina—nicknamed “Queen City”—where the company was founded.
By prioritizing natural healing and advanced regenerative treatments, QC Kinetix enhances patient mobility, function, and overall well-being. Under Dr. Sheinkop’s leadership, the company is well-positioned for continued success and medical innovation in the years ahead.
